LPL Financial LLC Sells 1,690 Shares of Prestige Consumer Healthcare Inc. $PBH

LPL Financial LLC cut its stake in Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report) by 4.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,508 shares of the company’s stock after selling 1,690 shares during the quarter. LPL Financial LLC owned 0.07% of Prestige Consumer Healthcare worth $2,881,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Opal Wealth Advisors LLC bought a new stake in Prestige Consumer Healthcare during the 1st quarter worth approximately $38,000. McIlrath & Eck LLC increased its stake in Prestige Consumer Healthcare by 19.1% during the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company’s stock worth $75,000 after purchasing an additional 154 shares in the last quarter. Johnson Financial Group Inc. bought a new stake in Prestige Consumer Healthcare during the 4th quarter worth approximately $93,000. Sterling Capital Management LLC increased its stake in Prestige Consumer Healthcare by 837.1% during the 4th quarter. Sterling Capital Management LLC now owns 1,593 shares of the company’s stock worth $124,000 after purchasing an additional 1,423 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its stake in Prestige Consumer Healthcare by 97.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 1,925 shares of the company’s stock worth $150,000 after purchasing an additional 950 shares in the last quarter. 99.95% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently issued reports on PBH shares. Wall Street Zen cut Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Canaccord Genuity Group lowered their target price on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating for the company in a research note on Friday, August 8th. Finally, Royal Bank Of Canada raised Prestige Consumer Healthcare to a “hold” rating in a research report on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of “Hold” and a consensus price target of $93.33.

Check Out Our Latest Analysis on Prestige Consumer Healthcare

Prestige Consumer Healthcare Trading Up 0.7%

NYSE:PBH opened at $65.06 on Monday. Prestige Consumer Healthcare Inc. has a twelve month low of $62.95 and a twelve month high of $90.04. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. The business has a 50 day moving average price of $77.27 and a two-hundred day moving average price of $81.62. The company has a market cap of $3.20 billion, a P/E ratio of 15.27, a price-to-earnings-growth ratio of 2.05 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing the consensus estimate of $1.01 by ($0.06). The company had revenue of $249.53 million during the quarter, compared to analyst estimates of $260.71 million. Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The company’s quarterly revenue was down 6.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.90 EPS. As a group, analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

About Prestige Consumer Healthcare

(Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Read More

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.